Literature DB >> 4346939

Plasmaphoresis and plasma exchange in the treatment of hyperlipaemia and xanthomatous neuropathy in patients with primary biliary cirrhosis.

L A Turnberg, M P Mahoney, M H Gleeson, C B Freeman, A H Gowenlock.   

Abstract

Two patients with primary biliary cirrhosis who were increasingly incapacitated by xanthomatous neuropathy are described. Treatment with a low fat diet and cholestyramine was unhelpful but repeated plasmaphoresis by simple venesection in one and plasma exchange using an IBM blood cell separator in the other over a period of several months completely relieved the symptoms of the neuropathy, caused skin xanthomata to recede, and lowered plasma lipid levels in both patients. There was no evidence that this procedure was associated with any deleterious effects on the liver. The size of the cholesterol pool in xanthomata in one patient was estimated to be approximately 35 g, and from the plasma cholesterol response to plasmaphoresis at varying frequency it was suggested that the excess of cholesterol synthesis over degradation was less than 0.3 g/day in one patient and less than 0.4 g/day in the other. On the basis of the response in these patients it is suggested that the turnover rates of lipid pools are relatively slow in biliary cirrhosis and that cholesterol accumulation is more likely to be due to a reduced catabolic rate than to an increased synthetic rate of cholesterol. Plasmaphoresis or plasma exchange are useful methods of treatment for the rare patient afflicted by this resistant and distressing complication of biliary cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4346939      PMCID: PMC1412500          DOI: 10.1136/gut.13.12.976

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  14 in total

1.  Xanthomatous neuropathy in primary biliary cirrhosis.

Authors:  P K Thomas; J G Walker
Journal:  Brain       Date:  1965-12       Impact factor: 13.501

2.  The metabolism of cholesterol in two hypercholesterolaemic patients treated with cholestyramine.

Authors:  C D Moutafis; N B Myant
Journal:  Clin Sci       Date:  1969-10       Impact factor: 6.124

3.  Comparison of membrane filtration and nephelometry with analytical ultracentrifugation, for the quantitative analysis of low density lipoprotein fractions.

Authors:  M C Stone; J M Thorp; G L Mills; T B Dick
Journal:  Clin Chim Acta       Date:  1970-12       Impact factor: 3.786

4.  Serum cholesterol in primary biliary cirrhosis.

Authors:  E Schaffner
Journal:  Gastroenterology       Date:  1969-06       Impact factor: 22.682

5.  Paradoxical elevation of serum cholesterol by clofibrate in patients with primary biliary cirrhosis.

Authors:  F Schaffner
Journal:  Gastroenterology       Date:  1969-09       Impact factor: 22.682

6.  Studies in the metabolism of cholesterol in subjects with normal plasma cholesterol levels and in patients with essential hypercholesterolaemia.

Authors:  B Lewis; N B Myant
Journal:  Clin Sci       Date:  1967-04       Impact factor: 6.124

7.  The late results of long-term treatment of primary biliary cirrhosis by corticosteroids.

Authors:  H T Howat; A J Ralston; H Varley; J A Wilson
Journal:  Rev Int Hepatol       Date:  1966

8.  Studies on the regulation of plasma cholesterol levels in squirrel monkeys of two genotypes.

Authors:  H B Lofland; T B Clarkson; R W St Clair; N D Lehner
Journal:  J Lipid Res       Date:  1972-01       Impact factor: 5.922

9.  A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects.

Authors:  D Seidel; P Alaupovic; R H Furman
Journal:  J Clin Invest       Date:  1969-07       Impact factor: 14.808

10.  Turnover of plasma cholesterol in man.

Authors:  D S Goodman; R P Noble
Journal:  J Clin Invest       Date:  1968-02       Impact factor: 14.808

View more
  8 in total

Review 1.  The hypercholesterolaemia of obstructive jaundice.

Authors:  N McIntyre; D S Harry; A J Pearson
Journal:  Gut       Date:  1975-05       Impact factor: 23.059

Review 2.  Lipoprotein apheresis.

Authors:  Vijay G Bhoj; Bruce S Sachais
Journal:  Curr Atheroscler Rep       Date:  2015-07       Impact factor: 5.113

3.  Effect of rifampicin in the treatment of pruritus in hepatic cholestasis.

Authors:  G V Gregorio; C S Ball; A P Mowat; G Mieli-Vergani
Journal:  Arch Dis Child       Date:  1993-07       Impact factor: 3.791

4.  Plasma exchange in primary biliary cirrhosis.

Authors:  P W Keeling; J Bull; P Kingston; R P Thompson
Journal:  Postgrad Med J       Date:  1981-07       Impact factor: 2.401

Review 5.  Lipoprotein apheresis in the management of familial hypercholesterolaemia: historical perspective and recent advances.

Authors:  Claudia Stefanutti; Gilbert R Thompson
Journal:  Curr Atheroscler Rep       Date:  2015-01       Impact factor: 5.113

6.  Role of plasmapheresis in primary biliary cirrhosis.

Authors:  L B Cohen; E P Ambinder; A M Wolke; S P Field; F Schaffner
Journal:  Gut       Date:  1985-03       Impact factor: 23.059

7.  Clinical, biochemical, and immunohistochemical features of necrobiotic xanthogranulomatosis.

Authors:  M Jeziorska; A Hassan; M I Mackness; D E Woolley; A B Tullo; G S Lucas; P N Durrington
Journal:  J Clin Pathol       Date:  2003-01       Impact factor: 3.411

Review 8.  Novel strategies and therapeutic options for the management of primary biliary cholangitis.

Authors:  Amardeep Khanna; David E Jones
Journal:  Therap Adv Gastroenterol       Date:  2017-09-07       Impact factor: 4.409

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.